Skip to content
Le Territoire Médical
Create an account

WHO Model List

epinephrine

International nonproprietary name (English: epinephrine). Brand names vary by country.

Indications retained by WHO

Anaphylaxis; Cardiac arrest; Asthma; Chronic obstructive pulmonary disease; Primary open-angle glaucoma (complementary list).

Listed forms and strengths

  • Parenteral > General injections > unspecified: 1 mg in 1 mL ampoule (as hydrochloride or hydrogen tartrate)
  • Parenteral > General injections > IV: 100 µg per mL in 10 mL ampoule (as acid tartrate or hydrochloride)
  • Local > Ophthalmological > Solution (eye drops): 2% (as hydrochloride)
  • Parenteral > General injections > unspecified: 1 mg per mL in ampoule (as hydrochloride or hydrogen tartrate)

Forms retained in the model list; presentations available in each country may differ.

General information from the WHO list. It replaces neither the prescription nor the leaflet: dosage and duration are for the doctor or pharmacist to decide.

Source: WHO electronic Essential Medicines List (2025 edition), checked on 14/11/2026. An error or an imprecision? Let us know